Sign Up Now Keep up to date with the latest blogs, books & events
Questions ? Call 1 (866) 877 6467 a 0 Items - $0.00

More Expensive, Ineffective Cholesterol-Lowering Medications Now Being Touted

  On March 10, 2018 at the annual American College of Cardiology (ACC) meeting, an “on the scene” video  was released reporting the results of the new PCSK9 cholesterol-lowering medication Praluent. (1)  This new class of LDL-cholesterol lowering medications works differently than statins.  PCSK9 inhibiters block an enzyme naturally...

Read More

New Cholesterol Drugs Protect High Risk Heart Patients: MORE FAKE NEWS!

In an on-line article in The New York Times today (3.17.17), the headline states, “Cholesterol-Slashing Drug Can Protect High-Risk Heart Patients, Study Finds.” The article describes the first test of the new cholesterol-lowering medication—Repatha. Repatha is part of the PCSK9 inhibiter family that works by lowering LDL-cholesterol levels through...

Read More

$14,000 For New Cholesterol-Lowering Drugs? We Must Be Out Of Our Minds!

Folks, Last Sunday (August 30, 2015) an article about the new cholesterol-lowering drugs appeared in the New York Times (NYT).  The article can be read here:  http://www.nytimes.com/2015/08/30/health/new-alternatives-to-statins-add-to-a-quandary-on-cholesterol.html?_r=1  The article focused on the side effects of statin drugs and it questioned if doctors will prescribe the new drugs even though they are...

Read More